<DOC>
	<DOCNO>NCT00304291</DOCNO>
	<brief_summary>Neuromyelitis optica ( NMO ) severe demyelinate disease selectively involve optic nerve spinal cord usually spar brain . NMO consider B cell induce pathogenesis . Mitoxantrone ( MITO , Novantrone® ) , synthetic anthracenedione approve worsen relapsing-remitting multiple sclerosis ( MS ) secondary progressive MS , show primarily suppress humoral response . We conduct prospective 2-year study evaluate benefit MITO five relapse NMO patient .</brief_summary>
	<brief_title>A Pilot Study Mitoxantrone Treatment Recurrent Neuromyelitis Optica ( Devic ’ Disease )</brief_title>
	<detailed_description>The treatment protocol consist monthly 12 mg/m2 MITO intravenous infusion 6 month follow 3 additional treatment every 3 month . Neurological assessment include determination Expanded Disability Status Scale ( EDSS ) score perform every 3 month relapse . Orbital , brain spinal cord MRI perform baseline , 3 , 6 , 12 , 18 , 24 month . Visual evoke potential ophthalmologic evaluation perform baseline annually .</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Neuromyelitis Optica</mesh_term>
	<mesh_term>Myelitis</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Autoimmune Diseases Nervous System</mesh_term>
	<mesh_term>Demyelinating Autoimmune Diseases , CNS</mesh_term>
	<mesh_term>Myelitis , Transverse</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<criteria>Recurrent longitudinal myelitis ( &gt; 3 segment spinal cord involvement MRI ) without recurrent ON ( unilateral bilateral ) normal brain MRI . Patients recurrent longitudinally extensive myelitis without optic neuritis underlie pathology serology similar NMO appropriate consider form NMO10 . Cerebrospinal fluid require intrathecal IgG synthesis oligoclonal band . Age required 1855 year Extended Disability Status Score ≤ 7 . Cardiac risk factor ( e.g history congestive heart failure leave ventricular ejection fraction ( LVEF ) &lt; 50 % Systemic diseases lupus , Sjogren ’ syndrome , antiphospholipid antibody syndrome , sarcoidosis , rheumatoid arthritis , vitamin B12 deficiency Previous treatment mitoxantrone anthracyclines</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Novantrone</keyword>
</DOC>